BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38537908)

  • 1. Development of a simple paste for 3D printing of drug formulations containing a mesoporous material loaded with a poorly water-soluble drug.
    Katsiotis CS; Tikhomirov E; Leliopoulos C; Strømme M; Welch K
    Eur J Pharm Biopharm; 2024 May; 198():114270. PubMed ID: 38537908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of mechanistic models to identify critical formulation and process variables of pastes for 3D printing of modified release tablets.
    Zidan A; Alayoubi A; Asfari S; Coburn J; Ghammraoui B; Aqueel S; Cruz CN; Ashraf M
    Int J Pharm; 2019 Jan; 555():109-123. PubMed ID: 30453019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3D-printing of solid lipid tablets from emulsion gels.
    Johannesson J; Khan J; Hubert M; Teleki A; Bergström CAS
    Int J Pharm; 2021 Mar; 597():120304. PubMed ID: 33540029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic application of twin-screw granulation and selective laser sintering 3D printing for the development of pharmaceutical dosage forms with enhanced dissolution rates and physical properties.
    Thakkar R; Zhang Y; Zhang J; Maniruzzaman M
    Eur J Pharm Biopharm; 2021 Jun; 163():141-156. PubMed ID: 33838262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of immediate release 3D-printed dosage forms for a poorly water-soluble drug by fused deposition modeling: Study of morphology, solid state and dissolution.
    Fanous M; Bitar M; Gold S; Sobczuk A; Hirsch S; Ogorka J; Imanidis G
    Int J Pharm; 2021 Apr; 599():120417. PubMed ID: 33647418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-Dimensional (3D)-Printed Zero-Order Released Platform: a Novel Method of Personalized Dosage Form Design and Manufacturing.
    Fang D; Yang Y; Cui M; Pan H; Wang L; Li P; Wu W; Qiao S; Pan W
    AAPS PharmSciTech; 2021 Jan; 22(1):37. PubMed ID: 33409925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Proof of Concept for 3D Printing of Solid Lipid-Based Formulations of Poorly Water-Soluble Drugs to Control Formulation Dispersion Kinetics.
    Vithani K; Goyanes A; Jannin V; Basit AW; Gaisford S; Boyd BJ
    Pharm Res; 2019 May; 36(7):102. PubMed ID: 31098846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simplification of fused deposition modeling 3D-printing paradigm: Feasibility of 1-step direct powder printing for immediate release dosage form production.
    Fanous M; Gold S; Muller S; Hirsch S; Ogorka J; Imanidis G
    Int J Pharm; 2020 Mar; 578():119124. PubMed ID: 32035253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An investigation into the use of polymer blends to improve the printability of and regulate drug release from pharmaceutical solid dispersions prepared via fused deposition modeling (FDM) 3D printing.
    Alhijjaj M; Belton P; Qi S
    Eur J Pharm Biopharm; 2016 Nov; 108():111-125. PubMed ID: 27594210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semi-solid extrusion 3D printing in drug delivery and biomedicine: Personalised solutions for healthcare challenges.
    Seoane-Viaño I; Januskaite P; Alvarez-Lorenzo C; Basit AW; Goyanes A
    J Control Release; 2021 Apr; 332():367-389. PubMed ID: 33652114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An investigation into the effects of ink formulations of semi-solid extrusion 3D printing on the performance of printed solid dosage forms.
    Zhang B; Belton P; Teoh XY; Gleadall A; Bibb R; Qi S
    J Mater Chem B; 2023 Dec; 12(1):131-144. PubMed ID: 38050731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fused deposition modeling 3D printing of solid oral dosage forms containing amorphous solid dispersions: How to elucidate drug dissolution mechanisms through surface spectral analysis techniques?
    Parulski C; Gresse E; Jennotte O; Felten A; Ziemons E; Lechanteur A; Evrard B
    Int J Pharm; 2022 Oct; 626():122157. PubMed ID: 36055443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Making tablets for delivery of poorly soluble drugs using photoinitiated 3D inkjet printing.
    Clark EA; Alexander MR; Irvine DJ; Roberts CJ; Wallace MJ; Yoo J; Wildman RD
    Int J Pharm; 2020 Mar; 578():118805. PubMed ID: 31715351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-loaded mesoporous silica on carboxymethyl cellulose hydrogel: Development of innovative 3D printed hydrophilic films.
    Schmidt LM; Dos Santos J; de Oliveira TV; Funk NL; Petzhold CL; Benvenutti EV; Deon M; Beck RCR
    Int J Pharm; 2022 May; 620():121750. PubMed ID: 35421531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 3D printed bilayer oral solid dosage form combining metformin for prolonged and glimepiride for immediate drug delivery.
    Gioumouxouzis CI; Baklavaridis A; Katsamenis OL; Markopoulou CK; Bouropoulos N; Tzetzis D; Fatouros DG
    Eur J Pharm Sci; 2018 Jul; 120():40-52. PubMed ID: 29678613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fabrication of Muco-Adhesive Oral Films by the 3D Printing of Hydroxypropyl Methylcellulose-Based Catechin-Loaded Formulations.
    Tagami T; Yoshimura N; Goto E; Noda T; Ozeki T
    Biol Pharm Bull; 2019; 42(11):1898-1905. PubMed ID: 31685772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can filaments, pellets and powder be used as feedstock to produce highly drug-loaded ethylene-vinyl acetate 3D printed tablets using extrusion-based additive manufacturing?
    Samaro A; Shaqour B; Goudarzi NM; Ghijs M; Cardon L; Boone MN; Verleije B; Beyers K; Vanhoorne V; Cos P; Vervaet C
    Int J Pharm; 2021 Sep; 607():120922. PubMed ID: 34303815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of immediate release (IR) 3D-printed oral dosage forms with focus on industrial relevance.
    Fanous M; Gold S; Hirsch S; Ogorka J; Imanidis G
    Eur J Pharm Sci; 2020 Dec; 155():105558. PubMed ID: 32946957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stabilisation of amorphous ibuprofen in Upsalite, a mesoporous magnesium carbonate, as an approach to increasing the aqueous solubility of poorly soluble drugs.
    Zhang P; Forsgren J; Strømme M
    Int J Pharm; 2014 Sep; 472(1-2):185-91. PubMed ID: 24950364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of 3D printing technology for generating hollow-type suppository shells.
    Tagami T; Ito E; Hayashi N; Sakai N; Ozeki T
    Int J Pharm; 2020 Nov; 589():119825. PubMed ID: 32861769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.